CONSTITUTIONAL ROBERTSONIAN T(15-22) IN PH-POSITIVE CML

被引：10
|
作者：
BECHER, R [1 ]
WENDT, F [1 ]
KUHN, D [1 ]
机构：
[1] EVANGEL KRANKENHAUS ESSEN WERDEN,HAMATOL & ONKOL ABT,D-4300 ESSEN,FED REP GER
来源：
HUMAN GENETICS | 1987年 / 76卷 / 04期
关键词：
D O I：
10.1007/BF00272453
中图分类号：
Q3 [遗传学];
学科分类号：
071007 ; 090102 ;
摘要：
引用
收藏
页码：399 / 399
页数：1
相关论文
共 50 条
  • [21] TRANSLOCATION [3-21] IN CHRONIC PHASE OF PH-POSITIVE CHRONIC MYELOGENOUS LEUKEMIA [CML]
    COYLE, T
    NAJFELD, V
    CYTOGENETICS AND CELL GENETICS, 1987, 46 (1-4): : 600 - 600
  • [22] UNBALANCED TRANSLOCATION 46,XY,-15,+DER(22),T(15-22)(GL3-Q11)PAT
    VANHOVE, J
    MCCONKIEROSELL, A
    CHEN, YT
    LANMAN, JT
    HENNESSY, MD
    KAHLER, SG
    AMERICAN JOURNAL OF HUMAN GENETICS, 1991, 49 (04) : 277 - 277
  • [23] The detection of Ph-positive cells by cytogenetic and fish analysis in interferon-treated patients with CML.
    Borovik, CL
    Bittencourt, EAA
    Loghin-Grosso, NS
    Guerra, JC
    Bacal, N
    AMERICAN JOURNAL OF HUMAN GENETICS, 1997, 61 (04) : A361 - A361
  • [24] PARTIAL MONOSOMY 15Q DUE TO DENOVO T(15-22)(Q15-P11)
    MORI, MA
    RODRIGUEZ, L
    PINEL, I
    CASAS, JM
    DEBUSTAMANTE, AD
    MARTINEZFRIAS, ML
    ANNALES DE GENETIQUE, 1987, 30 (04): : 246 - 248
  • [25] Extra BCR/ABL fusion mosaicism in 18p in a CML Ph-positive patient with erythroblastic transformation
    Vargas, MT
    Fernández-Novoa, CF
    Rodríguez, A
    Figueredo, A
    Reyes, J
    CANCER GENETICS AND CYTOGENETICS, 2006, 165 (02) : 185 - 186
  • [26] Therapeutic choices in patients with Ph-positive CML living in Mexico in the tyrosine kinase inhibitor era:: SCT or TKIs?
    Ruiz-Argulles, G. J.
    Tarin-Arzaga, L. C.
    Gonzalez-Carrillo, M. L.
    Gutierrez-Riveroll, K. I.
    Rangel-Malo, R.
    Gutierrez-Aguirre, C. H.
    Cantu-Rodriguez, O. G.
    Gomez-Almaguer, D.
    Giralt, S.
    BONE MARROW TRANSPLANTATION, 2008, 42 (01) : 23 - 28
  • [27] Therapeutic choices in patients with Ph-positive CML living in Mexico in the tyrosine kinase inhibitor era: SCT or TKIs?
    G J Ruiz-Argüelles
    L C Tarin-Arzaga
    M L Gonzalez-Carrillo
    K I Gutierrez-Riveroll
    R Rangel-Malo
    C H Gutiérrez-Aguirre
    O G Cantú-Rodríguez
    D Gómez-Almaguer
    S Giralt
    Bone Marrow Transplantation, 2008, 42 : 23 - 28
  • [28] Spectral karyotyping (SKY) refinement of a complex karyotype with t(20;21) in a Ph-positive CML patient submitted to peripheral blood stem cell transplantation
    Calabrese, G
    Fantasia, D
    Franchi, PG
    Morizio, E
    Stuppia, L
    Gatta, V
    Olioso, P
    Mingarelli, R
    Spadano, A
    Palka, G
    BONE MARROW TRANSPLANTATION, 2000, 26 (10) : 1125 - 1127
  • [29] Spectral karyotyping (SKY) refinement of a complex karyotype with t(20;21) in a Ph-positive CML patient submitted to peripheral blood stem cell transplantation
    G Calabrese
    D Fantasia
    PG Franchi
    E Morizio
    L Stuppia
    V Gatta
    P Olioso
    R Mingarelli
    A Spadano
    G Palka
    Bone Marrow Transplantation, 2000, 26 : 1125 - 1127
  • [30] Clonal chromosomal abnormalities in Ph-negative cells and clonal evolution in Ph-positive cells during treatment with Imatinib in a CML patient
    van Zelderen-Bhola, S. L.
    Verdonk, M. J. A.
    Nijhuis, J. V.
    Barge, R. M. Y.
    CHROMOSOME RESEARCH, 2005, 13 : 154 - 154
12345